The assay method used here is the competitive binding assay which involves the displacement of [3H]dofetilide from human recombinant ERG protein. The ERG protein is a direct single protein target assigned for the assay. The assay organism used is Homo sapiens, which is the human species. The assay type description for this method is binding, which refers to the binding of the ligand [3H]dofetilide with the ERG protein. Does the molecule show effectiveness in this assay?